Storia in 18 fonti

AstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks

Analysts warn mega-merger risks undermine AstraZeneca’s growth and innovation strategy

Raccontata da

cityam.com+6 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

businessday.co.zaStai leggendo17 h fa

AstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks

AstraZeneca and Bristol Myers in $400bn merger talks; AstraZeneca down 4.8% as investors question deal. Mega-merger risks disrupting R&D pipeline and attracting antitrust scrutiny (drug overlap); market rewards organic innovation over consolidation.

originale

Timeline cronologica

domenica 2 agosto 2026·handelsblatt.com
Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb
Es wäre eine der größten Fusionen in der Wirtschaftsgeschichte. Laut einem Medienbericht wurden entsprechende Gespräche geführt. Ob es zu einem Zusammenschluss kommt ist jedoch…
domenica 2 agosto 2026·valor.globo.com
AstraZeneca explora possível fusão com a Bristol Myers Squibb, diz jornal
União poderia criar gigante farmacêutica de US$ 400 bilhões em valor de mercado

AstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks

Confronto fonti

AstraZeneca shares fall amid reports of $400bn Bristol Myers Squibb merger talks

Timeline cronologica

Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb

AstraZeneca explora possível fusão com a Bristol Myers Squibb, diz jornal

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

AstraZeneca Stock Nosedives On Mega-Merger Rumor

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

Astrazeneca share price tumbles as investors doubt merger with US rival

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca said to have explored Bristol Myers merger | Fortune

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

Ft: AstraZeneca tratta con Bristol Myers Squibb fusione da 400 mld

AstraZeneca: Pharmakonzern prüft 400-Milliarden-Dollar-Fusion mit Bristol Myers

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca in talks over £300bn mega-merger with US rival – reports

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

Financial Times: 'AstraZeneca tratta con Bristol Myers Squibb per una maxi fusione da 400 miliardi' - Notizie - Ansa.it

AstraZeneca, BMS discuss $400B pharma mega-deal

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

Astrazeneca giù a Londra, per Ft tratta una mega-fusione con Bristol Myers Squibb

AstraZeneca pensa alla fusione con Bristol Myers Squibb: possibile colosso da 400 miliardi

Pharma: Mega-Fusion zwischen Astra Zeneca und Bristol Myers im Gespräch